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ABSTRACT 
 
Salacia lehmbachii leaves are used in Nigerian 
traditional medicine for the treatment of malaria and 
other diseases. The ethanolic extract was tested for 
its activities against suppressive, prophylactic and 
established infections in Plasmodium berghei 
infected albino mice at dose levels of 100, 200 and 
400 mg/kg; while chloroquine (10 mg/kg) was used 
as positive control. The extract exhibited significant 
dose-related antiplasmodial activities on parasites 
with the used-dose levels, showing significant mean 
survival time. The results, therefore, co-relate with 
claims by traditional users for the treatment of 
malaria and other feverish conditions; and could 
serve as source of potential new antimalarial  
agents. 
    
Keywords: Malaria; Salacia lehmbachii; Mice; 
Suppressive; Prophylactic; Curative. 
 
1. INTRODUCTION 
 
 Malaria is mosquito-borne plasmodial infec-
tion. It is a global killing parasitic disease, causing 
approximately up to 2 -3 million deaths annually, 
and still causing major setback to health in Sub-
Sahara Africa and other endemic areas [1, 2]. The 
annual occurrence of 400-500 million clinically 
newly-manifested cases portrays the severity of the 
disease, making it a global burden [3, 4]. It is of 
necessity to circumvent this global burden by 
widening research into new potential potent 
compounds with antimalarial activity, that are not 
based on existing synthetic antimalarial agents [5].  
Plants are widely accepted to contribute major parts 
of medications globally used by traditional healers. 
Some plants are notably known to be used against 
malaria [6], thus leading to increased scientific 
authentication of medicinal plants used in Nigeria  
as claimed by traditional users. 
 Salacia lehmbachii which belongs to 
Celastraceae family and genus of Salacia is one of 
such plants. It is a shrub-like to small tree of about 
three meters high, richly found in the tropical      
rain forest of Central, west and East Africa [7]. The 
leaves are seasonally evergreen, firm and difficult to 
slice. There are diverse therapeutic applications of 
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S. lehmbachii justifying its folkloric background; 
the leaf extract as an antipyretic [8] anti-diarrheal, 
antimotility and anti-ulcer properties [9], while the 
root extract exhibits analgesic/anti-inflammatory 
effect, anticholinergic property and anti-infertility  
in male [10-12]. The wet pad from the root is used 
in hemorrhoids [13].  
 
2. MATERIALS AND METHODS 
 
2.1. Collection and preparation of plant materials 
 
 The fresh leaves of S. lehmbachii Loes were 
collected in November, 2014 from fully grown plant 
in a local farm forest in Ukanafun, Akwa Ibom 
State, Nigeria. The plant materials were identified 
and authenticated by a taxonomist, Department of 
Botany, University of Calabar, where a voucher 
specimen (No. 688) is maintained. Internationally, 
the plant is indexed as “Salacia lehmbachii Loes. 
Bot. Jahrb.Syst.XLIV.(2-3) 173 (22/03/1910)”. The 
leaves were cleaned, cut into smaller pieces, air-
dried at room temperature (28-30oC) for 15 days and 
pulverized to dry powder with the help of mortar 
and pestle. 
 
2.2. Extraction of plant (leaf) material 
 
 Five hundred grams (500 g) of the dried-leaf 
powder was extracted in ethanol (BDH chemicals 
Ltd, England) using a Soxhlet extractor (Friedrich 
Polzine, England) and the filtrate were dried on a 
water bath at a controllable temperature. The yield 
was 12.5% w/w. The leave extract was subsequently 
reconstituted in normal saline for routine use during 
the study. 
 
2.3. Phytochemical analysis 
 
 The phytochemical screening of ethanolic   
leaf extract of S. lehmbachii was carried out           
for various secondary metabolites such as tannins 
(ferric chloride test), alkaloids (Mayer’s and 
Draggendorff reagents), saponins (Froth test), 
steroids (Liebermann-Burchard test), terpenoids 
(Salkowski test), flavonoids (ammonia and sul-
phuric acid test) and anthraquinones (Borntrager’s 
test) [14, 15]. 
 
2.4. Animals 
 
 The albino mice (18-22 g) of both sexes        
were obtained from animal house, Department         
of Pharmacology, College of Medical Sciences, 
University of Calabar, Nigeria. The animals were 
housed in cages under standard laboratory condi-
tions, with naturally illuminated environment of         
12 hrs dark and 12 hrs light cycles. They were         
fed on standard pellet diet and had free access             
to water. Care according to recommendation by 
Helsinki Declaration was implemented. Approval 
for study was obtained from the Research and 
Ethical Committee of Faculty of Basic Medical 
Sciences of University of Calabar. 
  
2.5. Acute toxicity study of the extract  
 
 The LD50 of the ethanolic extract of the      
leaf to authenticate the safety of the extract was 
determined as described by Lorke [16] method. All 
the doses were administered orally. During the          
two phases, the mice were observed for signs          
of toxicity for 48 hours. There was no overt evi-
dence of toxicity at the dose above 5000 mg/kg. 
 
2.6. Malaria parasites (donor) 
 
 The chloroquine sensitive P. berghei (NK65) 
was sourced from National Institute for Medical 
Research, Lagos Nigeria. Parasites are maintained      
in the Animal House of the Department of 
Pharmacology, College of Medical Science, 
University of Calabar by continuous re-inoculation 
of mice and affirmation of concentration of the 
parasites. 
 
2.7. Inocula  
 
 Parasitized erythrocytes for this study         
were obtained from a donor infected mouse                   
by cardiac puncture, and prepared according                 
to methods of Akuodor et al. [17] and David-Oku           
et al. [18]. To each mouse was administered 
intraperitoneally with infected blood suspension      
(0.2 ml) containing 1x107 P. berghei parasitized          
red blood cells. 
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2.8. Suppressive test 
 
 This study was carried out according to 
methods described by Akuodor et al. [19]. Thirty 
albino mice of both sexes were selected and 
passaged. After three hours, the infected mice         
were randomly divided into 5 groups, each cage 
containing 6 mice. Animals in each group were 
treated orally for four consecutive days (D0-D3) with 
100, 200, and 400 mg/kg of the ethanolic leaf 
extract, chloroquine diphosphate (10 mg/kg) and 
Normal saline (20 ml/kg) for positive and negative 
controls respectively.  On day five (D4), the films 
were prepared from tail blood of each mouse, and 
parasite concentration examined microscopically, 
counting the parasitized red blood cells on 1000 red 
blood cells in 10 different fields.  
 
2.9. Prophylactic study 
 
 This study was carried out according to the 
methods described by Peters et al. [20]. Thirty 
albino mice of both sexes selected for this study 
were grouped into 5 of 6 mice per cage. Groups 2-4 
were treated orally with graded doses of 100, 200, 
and 400 mg/kg of ethanolic extract of the leaf       
for four days (D0-D3); whilst group 1 and 5 received 
20 ml/kg of normal saline and 10 mg/kg of chloro-
quine diphosphate respectively. On the last day           
of treatment, mice in all groups were injected 
intraperitioneally with constituted P. berghei 
erythrocyte suspension. After 72 hours, films were 
prepared (as previously described) and examined 
microscopically.  
 
2.10. Curative test 
 
 On the first day, thirty Swiss albino mice 
were inoculated with P. berghei infected erythro-
cytes. After 72 hrs, the mice were randomly grouped 
into 5 groups of 6 mice, and treated daily (groups       
2-4) for four days with the extract (100, 200,             
and 400 mg/kg); while the animals in group 1 and    
5, were given 20 ml/kg of normal saline and 
chloroquine diphosphate (10 mg/kg). Thereafter, 
films were made and viewed to determine the 
parasite density. Mortality was monitored daily for 
mean survival time (MST), and the number of          
days from the time of inoculation of the parasite           
up to death was recorded for each mouse in the 
extract treated and control groups throughout the 
follow up period (D0-D29) [21].  
 
2.11. Statistical analysis 
 
 The obtained results were expressed as         
mean ± SEM. Data were analyzed using One-way 
ANOVA and differences between the means were 
considered significant at P< 0.05. 
 
3. RESULTS 
 
3.1.  Phytochemical test 
 
 Phytochemical results of the screened etha-
nolic extract of the leaf of S. lehmbachii revealed 
the presence of alkaloids, saponins tannins, 
terpenoides, flavonoids, phenols, steroids and 
anthraquinones while resin is absent (Table 1). 
 
 
Table 1. Phytochemical constituents of the ethanolic leaf 
extract of Salacia lehmbachii. 
Alkaloids ++ 
Saponins ++ 
Tannins + 
Terpenoids ++ 
Flavonoids + 
Phenols + 
Steroids + 
Anthraquinones + 
Balsam - 
Key: (+) = presence, (−) = absence 
 
 
3.2. Acute toxicity study of the extract  
 
 The acute toxicity test of the ethanolic leaf 
extract was negative. The LD50 was greater than 
5000 mg/kg orally, in tested mice.    
 
3.3. Suppressive effect 
 
 The ethanolic extract of the leaf showed          
a dose-related effect at different graded doses           
used. Doses of 200 and 400 mg/kg significantly            
(P < 0.05) produced 66.5% and 80.1% inhibition            
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of parasitaemia respectively, compared to 89.8% 
exhibited by 10 mg/kg of chloroquine (Table 2). 
 
 
Table 2. Suppressive effect of ethanolic extract of the 
leaf of S. lehmbachii against P. berghei in mice. 
Drug Dose (mg/kg) 
Mean 
parasitemia 
density 
% 
suppression 
Control 20 ml/kg 41.20±1.17 - 
S. lehmbachii 
100 25.00±1.12 39 
200 13.80±0.67* 67 
400 8.20±0.53* 81 
Chloroquine 10 4.20±0.53* 90 
Values represent the mean ± SEM (n=6), *significantly 
different from control at P< 0.05. 
 
 
Table 3. Prophylactic effect of ethanolic extract of the 
leaf of S. lehmbachii against P. berghei in mice. 
Drug Dose (mg/kg) 
Mean 
parasitemia 
density 
% 
suppression 
Control 20 ml/kg 40.40±1.18 - 
S. lehmbachii 
100 26.00±1.18 36 
200 11.40±0.47* 72 
400 5.80±0.53* 86 
Chloroquine 10 4.00±0.50* 90 
Values represent the mean ± SEM (n=6), *significantly 
different from control at P< 0.05 
 
 
3.4. Prophylactic effect 
 
 The leaf extract exhibited a dose-related 
effect at different doses used. Doses of 200 and          
400 mg/kg significantly (P< 0.05) prevented the 
replication of the invaded parasites by producing 
71.1% and 82.1% inhibition of parasitemia respec-
tively, compared 88.6% exhibited by 10 mg/kg of 
chloroquine (Table 3).   
 
3.5. Curative effect 
 
 The extract exhibited a significant dose-
dependent reduction in parasitemia density. The 
doses of 200 and 400 mg/kg produced significant 
(P< 0.05) effect comparable to the effect exhibited 
in chloroquine treated group; whilst in the negative 
group, there was a consistent increase in the blood 
parasites. The survival rate among the mice also 
reflected dose-dependent response and showed that 
the extract significantly (P< 0.05) destroyed the 
invaded parasites at (71.3 and 82.3 % for 200 and 
400 mg/kg respectively) of the established infection 
(Table 4). In the negative control group, from the  
9th day mice started dying, and by the 12th day, no 
mouse survived, whereas, in the positive control 
group (chloroquine treated), there was no death 
observed, Table 4. It is worthy to note that some 
mice which received 200 and 400 mg/kg survived 
the 30-day observation period. Photomicrographs of 
thin blood smears are on the Fig. 1. 
 
4. DISCUSSION  
 
 In this study, suppressive, prophylactic and 
curative antiplasmodial activities of S. lehmbachii 
were investigated in albino mice infected by            
P. berghei, which produces disease similar to those 
of human plasmodium infections, for the prediction 
of treatment outcomes [22]. 
 
 
Table 4. Data on curative effect of ethanolic extract of the leaf of S. lehmbachii against P. berghei in mice. 
Drug Dose (mg/kg) Mean parasitemia density % suppression 
  Pre-treatment Post-treatment  
Control 20 ml/kg 38.60±0.62 41.40±1.18 - 
S. lehmbachii 
100 40.20±1.86 25.53±0.37 37 
200 40.60±1.84 11.65±0.62* 71 
400 39.40±0.94 6.97±0.88* 82 
Chloroquine 10 39.00±1.04 2.26±0.34* 94 
Values represent the mean ± SEM (n=6), *significantly different from control at P< 0.05. 
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These parameters are accepted scientific methods 
for evaluating and identifying new potential 
antiplasmodial agents  [5, 18]. This usually deter-
mines the level of destruction of parasites in    
blood, hence a mean parasitaemia levels of about 
ninety percent mock-treated control animals indi-
cates that the test agent is potent in standard 
screening studies [23]. Therefore, the result could be 
used to show that S. lehmbachii leaf extract is 
capable of destroying or suppressing plasmodial 
growth to near non-detectable levels in the infected 
erythrocytes. 
 
 
Table 5. Mean survival time (days) of ethanolic extract 
of the leaf of S. lehmbachii against P. berghei in mice 
during curative study. 
Drug Dose (mg/kg) 
Mean survival 
time (days) 
Control 20 ml/kg 11.00±0.96 
S. lehmbachii 
100 20.80±1.65 
200 27.60±0.98* 
400 29.80±0.18* 
Chloroquine 10 30.00±0.00* 
Values represent the mean ± SEM (n=6), *significantly 
different from control at P< 0.05. 
 
 
A  B   
C  D  
E  
Figure 1. Photomicrographs of thin blood smears.            
A - untreated,  
B - 400 mg of the leaf extract (supressive),  
C - 400 mg of the leaf extract (prophylactic),  
D - 400 mg of the leaf extract (curative),  
E - 10 mg of chloroquine. 
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 The leaf extract, apart from exhibiting 
suppressive and prophylactic effects, also exerted 
significant curative activity during established 
infections. This could be seen in high percentage 
inhibition of parasites in blood as well as mean 
survival time especially in 200 and 400 mg/kg 
extract treated groups. It was recorded that some 
mice in these groups survived the 30 days of 
observation. However, the traditional use of                   
S. lehmbachii by herbalists could be attributed to the 
presence of certain phytochemicals identified in the 
leaf extract. Most medicinal plants possess a wide 
variety of important phytoconstituents such as: 
anthraquinones, flavonoids, alkaloids and terpenoids 
as their bioactive compounds. The activities of these 
compounds have been proved against plasmodial 
infections [24-26]. Thus, the exhibited antimalarial 
activities of S. lehmbachii leaf extract might be due 
to the presence of these compounds. S. lehmbachii 
leaf also possess phenols known for their anti-
oxidant and other diverse physiological properties: 
anti-carcinogenic, anti-inflammatory and anti-
parasitic activities [27]. 
 A standard antimalarial drug suppresses 
parasitemia significantly [28] which is in agree-
ment with the effect of chloroquine in this study.   
Chloroquine is both clinically used for suppressive, 
prophylactic and curative, treatment of malaria, 
except for resistant strains of Plasmodium falci-
parum [29]. It destroys plasmodia by preventing         
the digestion of hemoglobin, and blocking the 
parasites source of amino acids, or by inhibiting 
hem polymerase to prevent the production of 
hemozoin, a protective medium against autolysis. 
 
5. CONCLUSION 
 
 The results obtained from the present work 
have scientifically justified the reasons for the 
folkloric use of this local plant in the treatment           
of malaria attack in Nigerian traditional herbal 
practice. S. lehmbachii leaf extract has also proved 
to be a potential source of lead molecule(s) for the 
development of a new antimalarial agent. Further 
studies are however recommended to isolate and 
characterize the active ingredients responsible for 
the observed antimalarial activities. 
 
 
ACKNOWLEDGEMENT  
 
The authors are grateful to Mr. Frank I. Akpejoye, 
Department of Botany and Mr. Marcus Inyang, 
Department of Pharmacology, University of 
Calabar, Nigeria, for their botanical and technical 
assistance. 
 
AUTHORS’ CONTRIBUTION 
 
EAD and AGC designed and carried out the 
experiments, EGA wrote the first draft of the 
manuscript, NNN did extensive literature review, 
and AJL performed the statistical analysis, while 
USJ supervised the study. All authors read and 
approved the final manuscript. 
 
TRANSPARENCY DECLARATION  
 
The author declares no conflicts of interest.  
 
REFERENCES 
1. Tilley L, Dixon MW, Kirk K. The Plasmodium 
falciparum infected red blood cells. Int J Biochem 
Cell. 2011; 43(6): 839-842. 
2. Snow HW, Craig M, Deichmann U, Marsh K. 
Estimating mortality, morbidity and disability due to 
malaria among Africa’s non-pregnant population. 
Bull World Health Organ. 1999; 77: 624-640. 
3. Alilio MS, Bygbjerg IC, Breman JG. Are 
multilateral malaria researches and control programs 
the most successful? Lessons from the past 100 
years in Africa. Am J Trop Med Hyg. 2004; 71: 
268-278.  
4. Winstanley PA. Chemotherapy for falciparum 
malaria: the armoury the problems, and the 
prospects. Parasitol Today. 2000; 16: 146-153.    
5. Mojab F. Antimalarial natural products: a review. 
Avicenna J Phytomed. 2012; 2: 52-62. 
6. Adebayo JO, Krettli AU. Potential antimalarials 
from Nigerian plants: a review. J Ethnopharmacol. 
2011. 133: 289-302. 
7. Corstiaen PC, Sosef SM. Revision of African genus 
Annickia. Syst Geogr Plants. 2007; 77: 146-152. 
8. Essien AD, Akuodor GC, Essien EA, Asika EC, 
Chilaka KC, Nwadum SK. Evaluation of antipyretic 
potential of the ethanolic leaf extract of Salacia 
lehmbachii Loes. Asian J Med Sci. 2015; 7(2): 22-
25. 
130 | Essien et al.   Antiplasmodial effects of Salacia lehmbachii extract on Plasmodium berghei 
European Journal of Biological Research 2017; 7 (2): 124-130 
 
9. Essien AD, Essiet GA, Akuodor GC, Aja DO, 
Thomas EE. Studies on gastrointestinal properties of 
ethanolic leaf extract in Wistar rats. Afr J Pharm 
Pharmacol. 2016; 10(20): 451-457. 
10. Takem LP, Lawal BAS, Udia PM. Analgesic and 
acute anti-inflammatory activities of ethanolic root 
extract of Salacia lehmbachii. Brit J Pharmac Res. 
2014; 4(18): 2172-2181. 
11. Essien AD, Takem LP, Anele EI. In vitro 
cholinergic and acute toxicity evaluations Salacia 
lehmbachii. Int J Pharm Pharmac Res. 2015; 5(1): 
200-207.  
12. Essiet GA, Essien AD, Udoh FV, Essiet A. Anti-
fertility effects of ethanol extract of Salacia 
lehmbachii root bark in Albino rats. J Adv Med 
Pharmac Sci. 2016; 8(4): 1-8. 
13. Sofowora A. Medicinal plants and traditional 
medicine in Africa. Spectrum Books, Ibadan, 1993. 
14. Mukherjee PR. Quality control of herbal drugs, an 
approach to evaluation of botanicals. 13th edn. 
Business Horizones Publishers. New Delhi, 2006: 
419-459.  
15. Ajayi AO. Antimicrobial nature and use of some 
medicinal plants in Nigeria. Afr J Biotechnol. 2008; 
7(5): 595-599.  
16. Lorke E. A new approach for acute practical toxicity 
testing. Arch Toxicol. 1983; 54: 273-287.  
17. Akuodor GC, Idris-Usman M, Ugwu TC, Akpan JL, 
Ghasi SI, Osunkwo UA. In vivo schizonticidal 
activity of ethanolic extract of Gongronema 
latifolium on Plasmodium berghei in mice. 
Ibinosina J Med Biomed Sci. 2010; 2(3): 118-124.  
18. David-Oku E, Obiajunwa-Otteh JI, Akuodor GC, 
Essien AD. Evaluation of antimalarial potential of 
Icacina senegalensis Juss (Icacinaceae). Asian Pac J 
Trop Biomed. 2014; 4(suppl.2): 5819-5822.  
19. Akuodor GC, Amos GM, Essien AD, David-Oku E, 
Akpan JL, Ezeokpo BC. Antimalarial potency of the 
leaf extract of Aspilia africana (Pers) C.D. Adams. 
Asian Pac J Trop Med. 2012; 5: 126-129.  
20. Peters W, Robinso BL, Torey S, Rossier JC, Jefford 
CW. The chemotherapy of rodent malaria. Annu 
Trop Med Parasitol. 1993; 87: 111-123.  
21. Mbah CC, Akuodor GC, Anyalewechi NA, 
Iwunyanwu TC, Osunkwo UA. In vivo 
antiplasmodial activities of ethanolic extract of 
Bridelia ferruginea stem bark against Plasmodium 
berghei in mice. Pharm Biol. 2012; 50: 168-194.  
22. Mishra S, Sharma H, Mishra R, Gupta S. A review 
on antimalarial drug discovery and its screening 
method. World J Pharm Pharm Sci. 2014; 8: 1288-
1304. 
23. Trigg PI, Kondrachine AV. The current global 
malaria situation. In: Sherman IW, ed. Malaria: 
parasite biology, pathogenesis and protection. Am 
Soc Microbiol Press, 1998: 11-22.  
24. Ghildyal P, Gronhuag T, Rusten A, Skogsurd M. 
Chemical composition and immunological activities 
of polysaccharides isolated from the Malian 
medicinal plant Syzygium guineense. J  Pharmacogn 
Phytother. 2010; 2: 76-85. 
25. Otimenyin O, Umar M. Anti-inflamatory and 
analgesic activities of the ethanolic extract of the 
leaf of Syzygium guineense in rats and mice. IOSR J 
Pharm. 2012; 2: 33-36. 
26. Frederich M, Tits M, Angenot L. Potential 
antimalarial activity of indole alkaloids. Trans R 
Soc Trop Med Hyg. 2008; 102: 11-19. 
27. Tadesse SA, Wubneh ZB. Antimalarial activity of 
Syzygium guineense during early and established 
Plasmodium infection in rodent models. Complem 
Altern Med. 2017; 17: 21. 
28. Birhanu Z, Wuhab MA, Abula T. Antimalarial 
activity of Calpurnia aurea hydroalcoholic leaf 
extract in mice infected with Plasmodium berghei. 
JPHOL. 2015; 2: 73-79. 
29. Laurence DR, Bennett PN. Clinical pharmacology. 
7th edn. Churchill Livingstone. UK Ltd., 1994. 
 
